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Abstract
Background: The regeneration of integrity and tissue homeostasis after injury is a fundamental property and
involves complex biological processes fully dynamic and interconnected. Although there are medications
prescribed to accelerate the process of wound healing by reducing the exaggerated inflammatory response, comes
the need to search for different compounds of Amazonian biodiversity that can contribute to the acceleration of
the healing process. Among these products, the copaiba oil-resin is one of the most prominent feature in this
scenario, as they have been reported its medicinal properties.
Methods: Aiming to evaluate the anti-inflammatory and healing effect of copaiba oil-resin (Copaifera reticulata
Ducke) in transfixing injury of rats’ tongues first proceeded up the copaiba oil-resin oral toxicity test in 5 male mice
to stipulate the therapeutic dose which was established at 200 mg/kg/day. Then it was induced transfixing injury in
a total of 15 Wistar rats. The animals were randomly divided into three groups based on the treatment: control
group, dexamethasone group and copaiba oil-resin group. After 7 days of treatment, histological slides stained with
hematoxylin and eosin was prepared. Immunohistochemistry for CD68 (macrophage marker) was performed and
analyzed by the cell counter Image J.
Results: The acute toxicity test showed that the oil-resin copal has low toxicity. Furthermore, copaiba oil-resin
therapy modulates the inflammatory response by decreasing the chronic inflammatory infiltrate, edema and
specifically the number of macrophages.
Conclusions: The results indicate the potential of the Amazon region and showed up relevant because therapy
with this extract modulates the inflammatory process.
Keywords: Copaiba oil-resin, Inflammation, Complementary therapies, Macrophage, Model of injury, Amazonian
biodiversity, Copaifera Reticulata Ducke
Background
The Brazilian Amazon concentrates a large amount of
natural resources with various therapeutic applications in
alternative medicine. The oil-resin, copaiba, is a natural
product of the Amazon’s biodiversity more highlighted in
this scenery [1, 2], mainly due to its anti-inflammatory
and healing properties [2, 3]. Copaiba oil-resin is an
extracted exudate from trees in the genus Copaifera
(“copaibeiras”) that has more than 60 species cataloged in
the world [3]. Copaiba oil-resin is one of the most import-
ant renewable natural remedy for the populations of the
Amazon region [2].
Studies with copaiba oil-resin showed that this natural
product is formed by several components of the bases
diterpenes and sesquiterpenes, and the concentrations of
these compounds can vary according to species, soil
properties, climatic conditions, and the period of the
year when the extraction was done [3].
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Copaiba oil-resin is often used orally or topically [2].
Several studies using different species and in various
administration forms identified its anti-inflammatory
and wound healing property in different parts of the
body [4–10].
In the Amazon region, the species, Copaifera reticu-
lata Ducke, is the most frequently found and the most
often used. Due to this, copaiba oil-resin is found in very
popular street markets indicated treatments with injured
due to their possible anti- inflammatory activity and
healing [2].
Due to its widespread use, some scientific studies have
proposed identify the main therapeutic activities that
this compound had. From this, some studies in vitro and
in vivo have observed its larvicide activity [11] and anal-
gesic [12], antioxidant [2], anxiolytic [13], and antimicro-
bial [14], and inhibition of microglial and neutrophilic
activation [15]. In addition to these properties, some
studies have found the use of this species to be safe, and
neither high toxicity nor teratogenic activity in preg-
nancy has been observed [16, 17].
Considering the complexity of repair tissue physiology
and the structural and functional damage incurred due
to wounds, it is necessary to search for different com-
pounds that can contribute to the reduction of the in-
flammatory response and to accelerate the healing
process. Our study evaluates the anti-inflammatory
properties of copaiba oil-resin (Copaifera reticulata
Ducke) in a model that transfixes injury in rats’ tongues.
Methods
Plant material, oil-resin extraction and caracterization
For oil-resin collection were used dispersed native adult
plants of Copaifera reticulata Ducke over 30 years old
located in the municipality of Belterra, Pará, Brazil. The
trees were randomly drilled with a traditional auger
2 cm diameter and 45 cm in length, making up two
holes in the height of 1 m and 1.50 m, respectively. Oil-
resin samples were stored in plastic containers (2000 ml)
by the action tree and protected from light with
aluminum foil. Subsequently, they were transferred to
glass jars (20 ml) for further analysis. The bore of the
tree after the complete draining of the oil-resin pipe was
sealed with PVC type with a diameter of ¾ and 10 cm
long containing a plastic cap in order to facilitate collec-
tion and avoid other waste wood. A copy of the plant
species deposited in the Herbarium IAN EMBRAPA
Eastern Amazon (Exsicata: 183,939). The method of
chemical characterization of copaiba oil-resin has been
described by Santos-Guimarães et al., 2012 [15].
Experimental animals
A total of 15 adult male Wistar rats (3 months old), ob-
tained from the Federal University of Pará (UFPA) were
kept in collective cages (5 animals per cage) and more 5
mice (Mus musculus) adult male Swiss. Animals were
maintained in a climate-controlled room with a 12 h
light-dark cycle (lights on 7:00 AM) and food and water
ad libitum. All procedures were approved by the Ethics
Committee on Experimental Animals of the Federal
University of Pará (license number BIO-203-14), following
the Guide for the Care and Use of Laboratory Animals.
Acute oral toxicity test (OECD, 2008)
A test for acute oral toxicity was performed, according
to the Guide 425/2008 from the Organization for Eco-
nomic Co-operation and Development (OECD) [18],
where the estimation of the LD50 was estimated using
the limit test method. In this study, a single Swiss albino
mouse (Mus musculus), weighing 20 to 30 g, received a
dose of 2000 mg/kg and were observed for 48 h. If the
animal survived, the other 4 animals were sequentially
tested with the same dose. The survival of 3 or more an-
imals qualifies as the LD50 greater than 2000 mg/kg
(low toxicity).
If the first animal should die or deaths were greater
than or equal to three of five animals, would follow-up
for the main test. Another animal received 175 mg/kg
orally. If the animal survived, another animal was tested
with a higher dose (range of 3.2×) until a dose resulted
in death or overt toxicity. When the first animal of the
main test manifested obvious intoxication or death, the
following animal received a lower dose (range of 3.2×).
The test continued until 3 consecutive animals survived
the upper limit dose (2000 mg/kg) or 5 recoveries oc-
curred in any of the 5 animals tested consecutively, and
at least 4 animals recovered.
In this model, all animals were observed individually
for 30 min after administering the dose and then evalu-
ated periodically during the 48 h following surgery. In
this evaluation, toxic manifestations were observed, such
as changes in skin, fur, eyes, and mucous membranes.
Toxicity was also evident in the animals’ circulatory, re-
spiratory, autonomic and central nervous systems and in
locomotor behavior. The tests evaluating copaiba oil-
resin effects were carried out with doses equivalent to
10% of the lowest dose that caused the deaths of at least
three animals.
Induction of transfixing injury and experimental groups
The transfixing lesions were induced by first placing an
Ainsworth clamp on the previous third of the tongue. The
animals were anesthetized with ketamine (90 mg/kg, ip)
and xylazine (10 mg/kg, ip). Soon after, the animals were
positioned supine on a flat area and had the tongue ex-
posed. With the aid of two Perry tweezers, which bored
into the body to produce injury, two perforations were
carried out: one in the right lobe of the tongue and one on
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the left lobe to form standard, traumatic injuries. After
surgery the animals were kept with water and food ad libi-
tum in individual cages and divided into the following
groups: a control group, a dexamethasone group, and a
copaiba oil-resin group, each group n = 5. All animals
were let to recover for 7 days.
Animal treatment
Twelve hours after surgery, animals assigned to the co-
paiba oil-resin group received 10% of the dose set by the
acute oral toxicity test; the control group received a dose
of Tween® 20 corresponding to the volume of the dose
given to the animals in the copaiba oil-resin group.
Animals of the third group were treated with dexa-
methasone and received a dose of 0.5 mg/kg/day [19].
All treatments were performed by intragastric gavage
(oral route).
Obtaining of samples and histological procedures
After the stipulated survival time, animals were deeply
anesthetized with ketamine (90 mg/kg, ip) and xylazine
(10 mg/kg, ip) and euthanized by cervical dislocation.
Tongues were removed and fixed in 10% formalin for at
least 48 h. After this period, the specimens were washed
with distilled water, dehydrated in progressive concen-
trations alcohol solutions, cleared in xylene, and embed-
ded in paraffin. Five μm sections were obtained for
hematoxylin and eosin (HE). Figure 1 depicts the sche-
matic drawing of the applied methodology.
Histopathological evaluation
The qualitative and semi-quantitative analyses of HE
stained slides were performed by two blinded examiners
using a conventional light microscope. For qualitative ana-
lysis (descriptive evaluation) the following histopatho-
logical features were described: edema, inflammatory
infiltrate, angiogenesis and muscle fibers. After that, semi-
quantitative analysis (scores evaluation) of edema and
inflammatory infiltrate were performed using a grading
system: Grade 0 (absent), Grade 1 (mild), Grade 2 (moder-
ate) and Grade 3 (severe or intense) based on Wagner.
2013 [20] and Coelho. 2015 [21]. The examiners were
previosly calibrated and Kappa coefficient test (p > 0.7)
were calculated to determine the concordance of
score analysis.
Immunohistochemistry
For immunohistochemical staining, the samples were sec-
tioned into 3-μm sections and placed on silanized slides.
The slides were deparaffinized in xylene and hydrated in
descending grades of ethanol. Antigen retrieval was per-
formed prior to incubation of the primary antibody. The
primary antibody, sources, antigen retrieval, dilutions and
incubation times were as follows: CD68 (ED1, AbD Serotec,
low pH solution in a water bath at 90 °C for 18 h, 1:100,
2 h). The sections were then incubated with diaminobenzi-
dine tetrahydrochloride (DAB, Novocastra, Newcastle, UK)
and counterstained with Mayer’s hematoxylin. Negative
controls were obtained by replacing the primary antibody
with non-immune serum. The positive control were sec-
tions of human tonsil for CD68.
All immunohistochemical analysis was performed by
one blinded observer of the treatment received. Five im-
ages of the wound healing area were captured at a mag-
nification of 400× using a conventional light microscope
(CX41RF model, Olympus Latin America, Inc., Miami,
Florida, USA) coupled to a camera (QColor 5, RTV,
Olympus Inc., BX51, Canada) and connected to a com-
puter (Dimension 5150, Dell, Porto Alegre, RS, Brazil)
using the QCapture software program, version 2.81
(Quantitative Imaging Corporation, Inc., Surrey, British
Columbia, Canada). The images were analyzed using
Image J software program (National Institute of Mental
Health, Bethesda, Maryland, USA). The slides, stained
with CD68, were analyzed and only the cells with cyto-
plasmic brown labeling were considered positive.
Fig. 1 Schematic representation of the experimental design utilized in the present study
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Statistical analysis
The results obtained in the various assessments were en-
tered into GraphPad Prism 5.0 software. The nonpara-
metric Kruskal-Wallis test was used with a significance
level of p < 0.05 for evaluation of data for scores. For
quantitative evaluation of immunohistochemical assays
we used ANOVA with post 1 via a Tukey test. Results
were expressed textually and graphically with means and
standard error (mean ± SE).
Results
Oil-resin characterization
The copaiba oil-resin used in this research was extracted
from the species, Copaifera reticulata Ducke, and has
been characterized by Guimarães-Santos et al. in 2012 [8].
For this study, 27 components were identified with the
following concentrations: δ-elemene (0.2%), cyclosativene
(0.9), α-copaene (0.5%), δ-elemene (0.2%), cyclosativene
(0.9%), α-copaene (0.5%), β-elemene (3.2%), α-gurjunene
(0.7%), β-caryophyllene (37.3%), trans-α-bergamotene
(9.0%), aromadendrene (0.9%), epi-β-santalene (0.1%), α-
humulene + (E)-β-farnesene (5.4%), β-chamigrene (1.0%),
γ-gurjunene (0.6%), γ-curcumene (0.6%), β-selinene (4.8%),
α-selinene (3.0%), (Z)-α-bisabolene (1.8%), α-bulnesene
(2.2%), β-bisabolene (14.5%), β-curcumene (0.4%), β-
sesquiphelandrene (1.2%), (E)-γ-bisabolene (1.4%), caryo-
phyllene oxide (0.1%), epi-β-bisabolol (0.1%), and β-bisabolol
(0.2%).
Acute oral toxicity test
On the acute oral toxicity test, none of the 5 animals
tested with the limit dose (2000 mg/kg/day) died or had
any sign or symptom of toxicity during the 48-h test.
Thus, the dose prescribed for this study was 10% of the
limit dose, i.e., the copaiba oil-resin group of animals re-
ceived 200 mg/kg/day and the control animals received
200 mL/kg/day of Tween 20.
Qualitative histopathological analysis
The proposed lesion induction model produced an ex-
tensive wound to the two surfaces of the tongue, reach-
ing all the constituents of the animals’ body tissue,
Fig. 2 Effect of treatment with copaiba oil-resin on transfixing lesions in rats’ tongues stained by hematoxylin and eosin (HE). Panels (a and b)
represent the control group. Panels (c and d) represent the dexamethasone group. Panels (e and f) represent the copaiba oil-resin group. It is
found that the groups dexamethasone and copaiba oil-resin showed similar aspects decreasing chronic inflammatory infiltration and edema,
compared to the control group
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including epithelial tissue, connective tissue, and muscle
tissue. The transfixing injury promoted a deep character
injury.
Thus, the major differences were found in a histo-
pathological analysis at this deepest portion of the
wound, particularly in the muscle tissue of all groups.
Through qualitative analysis in HE, the control group
(Fig. 2a and b) exhibited moderate chronic inflammatory
infiltrate, represented by the presence of lymphocytes,
plasma cells, and macrophages and accompanied by ex-
tensive edema. The formation of the angiogenesis
process was also observed along with little formations of
immature muscle fibers.
The dexamethasone groups (Fig. 2c and d) and co-
paiba oil-resin (Fig. 2e and f) showed similar aspects to
each other, but when compared to the control group
showed less chronic inflammatory infiltrate and greater
formation of muscle fibers in the injury area. Thus, both
treatments showed anti-inflammatory action and accel-
erated the repair in the area.
The histological sections of the dexamethasone group
showed less edema, which did not occur in the control
group or in the copaiba oil-resin group. Neither group
appeared to have the presence of fibrosis or necrosis.
Semi-quantitative analysis of inflammatory infiltrate and
edema
From the analysis score shown in Fig. 3, treatment with co-
paiba oil-resin in the proposed model was able to demon-
strate anti-inflammatory action, it decreased the intensity
of chronic inflammatory infiltrate (1.2 ± 0.20) compared to
the control group (2.0 ± 0.0), and its performance was
similar to the dexamethasone group (1.0 ± 0.0).
When evaluating the variable edema from the analysis
score, we found treatment with the copaiba oil-resin
even reduced the intensity of edema (1.8 ± 0.20) but it
was not a statistically significant difference compared to
the control group (2.4 ± 0:24). Treatment with dexa-
methasone also decreased the intensity of edema
(0:25 ± 0:25) compared to the control group; however,
there was no difference from the group treated with co-
paiba oil-resin.
Immunohistochemistry analysis
The treatment with dexamethasone and copaiba oil-resin
reduced the number of CD68 positive macrophages. How-
ever, a significant reduction was only observed in the co-
paiba oil-resin group compared to the control group
(p = .0432, Fig. 4).
Discussion
This study was the first to investigate the effects of co-
paiba oil-resin on factors that modulate inflammation of
oral tissue. Research has demonstrated that copaiba oil-
resin (Copaifera reticulata Ducke) could modulate the
inflammatory process by decreasing the recruitment of
inflammatory cells after 7 days of oral treatment.
Regeneration of integrity and tissue homeostasis after
injury is a fundamental property and one of the most
complex biological processes that occur during the life
of all organisms. Mammals’ response to injury requires a
complex and dynamic interaction of numerous cellular
and humoral cascades that have the purpose of perform-
ing a sequence of repair steps, comprising inflammation,
tissue proliferation, and maturation of tissue [22–25].
Inflammation comprises the first phase of tissue repair
where neutrophils are recruited immediately after injury
and persist in large numbers through the first 48 h after
the injury. Then, monocytes arise from the bloodstream
and differentiate into macrophages, which phagocytize
Fig. 3 Effect of treatment with copaiba oil-resin on transfixing lesions
in rats’ tongues comparing intensities of chronic inflammatory infiltrate
and edema. The results are expressed as mean ± SE of the scores
attributed to each variable analyzed. Panel (a): variable chronic
inflammatory infiltrate; Panel (b): variable edema (n = 5 animals per
group). *p ≤ .05 compared to control group (Kruskal-Wallis test,
followed by Dunn test)
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bacteria and dead cells under the influence of other cel-
lular elements, such as lymphocytes. These inflammatory
cells are crucial to the healing process [22, 23]. Thus,
the model used in this study mainly assessed the chronic
inflammatory infiltrate since the animal’s survival period
after injury was 7 days, and was, therefore, composed of
lymphocytes, plasma cells, and macrophages.
The modulation of the inflammation is fundamentally
important because, during the inflammatory phase, there
is a release of growth factors that induce proliferation of
fibroblasts with a consequent production of extracellular
matrix and myofibroblasts, which are the basis for the
healing/reshuffle [22, 24].
Different therapeutic protocols, such as analgesics, corti-
costeroids, and anti-inflammatory agents have been tested
to accelerate the wound healing process. In addition to
these drugs, the pharmaceutical industry has focused re-
search on alternative medicine, and it takes as its first
ground empirical knowledge of needy populations who use
nature’s products as needed to treat their diseases [25–28].
In this scenario, products arising from the Amazon re-
gion, many of which have unknown composition, arise
Fig. 4 Effect of treatment with copaiba oil-resin on transfixing lesions in rats’ tongues comparing the CD68-positive cells. a Photomicrographs
showing CD68-positive cells (arrows) in control, dexamethasone and oil copaiba Groups. b Graphic illustrating the number of CD68-positive cells
in three different treatments (n = 5 animals per group). *p ≤ .05 compared to control group (one-way ANOVA with Tukey’s post-hoc test)
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as possible alternatives for future drug formulations.
Among these, one that is most prominent is copaiba oil-
resin. Copaiba oil-resin is a natural substance obtained
from the trunk of the copaifera tree, originally from the
Amazon rainforest, and has been used for over 500 years
in traditional folk medicine in the region with great di-
versity of applications.
This natural substance is obtained by drilling the trunk
of the copaifera tree, which belongs to the family
Leguminosae-Caesalpiniaceas, featuring a variety of species.
One that stands out in the Amazon is Copaifera reticulated
Ducke [2, 29, 30], the same used in this investigation.
The method of testing for acute oral toxicity, as used
in our study, is among the most currently accepted in
literature [26]. Although other studies have used other
methods also advocated by the OECD, they observed
that copaiba oil-resin intake by the rat species used in
our investigation caused no acute oral toxicity, confirm-
ing our findings and, once again, demonstrating safe use
of this extract by mouth [24, 25].
The lesion induction method is a model developed in
our laboratory which can identify the repair process in all
the extension of the organ, since the gripper Ainsworth
damage all tissues that constitute language (epithelial
tissue, connective and muscle). We can observe in the
literature other types of induction of injury in the rat
tongue using punch [20] and mucositis induction [21],
however, neither described able to reach all tissues that
constitute tongue.
Copaiba oil-resin’s modulating effect on inflammation
that presented in the transfixing injury in rats’ tongues
may be attributed to sesquiterpene β-caryophyllene. This
compound represents about 40% of copaíba oil-resin’s
composition as reported in the literature [2]. The oil-
resin used in our survey has 37% of β-caryophyllene.
The literature has shown that this high β-caryophyllene
content is primarily responsible for the anti-inflammatory
characteristic of copaíba oil-resin [16], as it has been re-
ported that this compound performs selective binding and
inhibiting in canabioide receptor type 2 (CB 2). The acti-
vation of CB 2 receptors are involved in stimulating the
secretion of pro-inflammatory cytokines and increasing T
and B lymphocyte response [31, 32].
Our results demonstrate that copaiba oil-resin reduced
the number of inflammatory cells after 7 days of injury,
which is similar to that found in animals treated with
dexamethasone. Dexamethasone anti-inflammatory ac-
tivity has been well-described in the literature and corre-
sponds to adhesive inhibition effects and migration of
leukocytes, inducing apoptosis of inflammatory cells, re-
duction of edema, and suppression of the production of
inflammatory mediators by inhibiting phospholipase A2
and induction of anti-inflammatory cytokine IL-10 [33].
However, steroids have been associated with numerous
local and systemic side effects [34], and thus the use of
other agents, such as copaiba oil-resin oil, reduces in-
flammation and accelerates cellular repair without caus-
ing adverse effects.
The difference in the formation of edema found in treat-
ments with dexamethasone and copaiba oil-resin is because
of differences between the two anti-inflammatory mecha-
nisms of the treatments. However, regardless of the amount
of swelling, both groups had reduced numbers of inflam-
matory cells and favored the formation of new fibers.
Conclusion
The results indicate that copaiba oil-resin is a natural
product effective in reducing chronic inflammatory infil-
trate and inhibiting macrophage activity. For not pre-
senting effectiveness of reduction of edema, our data
direct to new investigations that seek to elucidate the
role of this oil-resin on other mechanisms associated
with inflammation.
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